|
JPS63276054A
(ja)
|
1987-05-07 |
1988-11-14 |
Hitachi Chem Co Ltd |
電子写真感光体
|
|
CA2009925C
(en)
|
1989-02-14 |
2002-10-01 |
Koichi Kondo |
Method for enhancement of chemiluminescence
|
|
EP0553009B1
(fr)
|
1992-01-23 |
1997-06-04 |
Institut Francais Du Petrole |
Catalyseur d'alkylation de paraffines
|
|
DE69330713T2
(de)
|
1992-03-13 |
2002-07-04 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Imidazol-, triazol- und tetrazolderivate
|
|
US5348969A
(en)
|
1992-04-03 |
1994-09-20 |
Bristol-Myers Squibb Company |
Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
|
|
WO1994008982A1
(fr)
|
1992-10-13 |
1994-04-28 |
Nippon Soda Co., Ltd. |
Derives oxazole et thiazole
|
|
ATE202571T1
(de)
|
1993-09-14 |
2001-07-15 |
Merck & Co Inc |
Humane protein-tyrosinphosphatase decodierende cdna
|
|
US5616601A
(en)
|
1994-07-28 |
1997-04-01 |
Gd Searle & Co |
1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
|
|
US5700816A
(en)
|
1995-06-12 |
1997-12-23 |
Isakson; Peter C. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
|
|
DE69635048T2
(de)
|
1995-06-12 |
2006-02-16 |
G.D. Searle & Co. |
Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
|
|
US5753687A
(en)
|
1995-06-19 |
1998-05-19 |
Ontogen Corporation |
Modulators of proteins with phosphotryrosine recognition units
|
|
US6388076B1
(en)
|
1995-06-19 |
2002-05-14 |
Ontogen Corporation |
Protein tyrosine phosphatase-inhibiting compounds
|
|
JP3849157B2
(ja)
|
1995-08-01 |
2006-11-22 |
東ソー株式会社 |
２−イミダゾリン類の製造法
|
|
US6238902B1
(en)
|
1996-03-22 |
2001-05-29 |
Genentech, Inc. |
Protein tyrosine phosphatases
|
|
US5958957A
(en)
|
1996-04-19 |
1999-09-28 |
Novo Nordisk A/S |
Modulators of molecules with phosphotyrosine recognition units
|
|
CA2275610A1
(en)
*
|
1996-12-16 |
1998-06-25 |
Ontogen Corporation |
Modulators of proteins with phosphotyrosine recognition units
|
|
US5840721A
(en)
|
1997-07-09 |
1998-11-24 |
Ontogen Corporation |
Imidazole derivatives as MDR modulators
|
|
GB9715816D0
(en)
|
1997-07-25 |
1997-10-01 |
Black James Foundation |
Histamine H receptor ligands
|
|
FR2767527B1
(fr)
|
1997-08-25 |
1999-11-12 |
Pf Medicament |
Derives de piperazines indoliques, utiles comme medicaments et procede de preparation
|
|
CA2298601A1
(en)
|
1997-08-28 |
1999-03-11 |
Pharmacia & Upjohn Company |
Inhibitors of protein tyrosine phosphatase
|
|
WO1999015529A1
(en)
|
1997-09-23 |
1999-04-01 |
Novo Nordisk A/S |
MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
|
|
US5972986A
(en)
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
|
US6159944A
(en)
*
|
1998-02-27 |
2000-12-12 |
Synchroneuron, Llc |
Method for treating painful conditions of the anal region and compositions therefor
|
|
US6262044B1
(en)
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
|
US20020002199A1
(en)
|
1998-03-12 |
2002-01-03 |
Lone Jeppesen |
Modulators of protein tyrosine phosphatases (ptpases)
|
|
US6699896B1
(en)
|
1998-05-12 |
2004-03-02 |
Wyeth |
Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
|
|
CA2331056A1
(en)
|
1998-05-12 |
1999-12-02 |
Wyeth |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
|
|
US20030194745A1
(en)
|
1998-06-26 |
2003-10-16 |
Mcdowell Robert S. |
Cysteine mutants and methods for detecting ligand binding to biological molecules
|
|
JP2004514402A
(ja)
|
1998-07-24 |
2004-05-20 |
メルク フロスト カナダ アンド カンパニー |
プロテインチロシンホスファターゼ−１ｂ（ｐｔｐ−１ｂ）欠失マウスおよびその使用
|
|
US6174874B1
(en)
|
1998-09-21 |
2001-01-16 |
Merck Frosst Canada & Co. |
Phosphonic acids derivatives as inhibitors of protein tyrosine phosphate 1B (PTP-1B)
|
|
AU1543600A
(en)
|
1998-12-11 |
2000-07-03 |
Mcgill University |
Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
|
|
JP4221129B2
(ja)
|
1999-02-15 |
2009-02-12 |
富士フイルム株式会社 |
含窒素ヘテロ環化合物、有機発光素子材料、有機発光素子
|
|
CA2372116A1
(en)
|
1999-05-14 |
2000-11-23 |
Claude Dufresne |
Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b)
|
|
EP1070708B1
(en)
|
1999-07-21 |
2004-01-14 |
F. Hoffmann-La Roche Ag |
Triazole derivatives
|
|
DE60023920T2
(de)
|
1999-08-27 |
2006-07-20 |
Sugen, Inc., South San Francisco |
Phosphatmimetika und Verfahren zur Behandlung mit Phosphataseinhibitoren HIBITOREN
|
|
US6410556B1
(en)
|
1999-09-10 |
2002-06-25 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphateses (PTPases)
|
|
AU7961100A
(en)
|
1999-10-28 |
2001-05-08 |
Daiichi Pharmaceutical Co., Ltd. |
Drug discharge pump inhibitors
|
|
DE50009208D1
(de)
|
1999-11-25 |
2005-02-17 |
Ciba Sc Holding Ag |
Hydroxyphenylvinylthiazole
|
|
US6486142B2
(en)
|
1999-12-22 |
2002-11-26 |
Merck Frosst Canada & Co. |
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
|
|
CA2393363A1
(en)
|
1999-12-22 |
2001-06-28 |
Merck Frosst Canada & Co. |
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
|
|
US6777433B2
(en)
|
1999-12-22 |
2004-08-17 |
Merck Frosst Canada & Co. |
Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
|
|
AU2335701A
(en)
|
1999-12-22 |
2001-07-03 |
Merck Frosst Canada & Co. |
Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
|
|
WO2001046204A1
(en)
|
1999-12-22 |
2001-06-28 |
Merck Frosst Canada & Co. |
Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
|
|
JP2003520049A
(ja)
|
2000-01-18 |
2003-07-02 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
ヒトタンパク質であるチロシンホスファターゼのポリヌクレオチド、ポリペプチド、および抗体
|
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
|
AU2001238458A1
(en)
|
2000-02-14 |
2001-08-27 |
Ceptyr, Inc. |
Improved assay for protein tyrosine phosphatases
|
|
JP2003528106A
(ja)
|
2000-03-22 |
2003-09-24 |
メルク フロスト カナダ アンド カンパニー |
Ｐｔｐ−１ｂ阻害薬としての硫黄置換アリールジフルオロメチルホスホン酸類
|
|
US6627647B1
(en)
|
2000-03-23 |
2003-09-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents
|
|
US6911468B2
(en)
|
2000-05-22 |
2005-06-28 |
Takeda Chemical Industries, Ltd. |
Tyrosine phosphatase inhibitors
|
|
JP2004502754A
(ja)
|
2000-07-06 |
2004-01-29 |
アレー バイオファーマ インコーポレイテッド |
ホスファターゼ阻害剤の調製
|
|
US6613903B2
(en)
|
2000-07-07 |
2003-09-02 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPases)
|
|
US20020099073A1
(en)
|
2000-07-07 |
2002-07-25 |
Andersen Henrik Sune |
Modulators of protein tyrosine phosphatases (PTPases)
|
|
US20020169157A1
(en)
|
2000-08-29 |
2002-11-14 |
Gang Liu |
Selective protein tyrosine phosphatatase inhibitors
|
|
US6472545B2
(en)
|
2000-08-29 |
2002-10-29 |
Abbott Laboratories |
Protein tyrosine phosphatase inhibitors
|
|
US20020035137A1
(en)
|
2000-08-29 |
2002-03-21 |
Gang Liu |
Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors
|
|
US6972340B2
(en)
|
2000-08-29 |
2005-12-06 |
Abbott Laboratories |
Selective protein tyrosine phosphatatase inhibitors
|
|
US6627767B2
(en)
|
2000-08-29 |
2003-09-30 |
Abbott Laboratories |
Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
|
|
GB0022079D0
(en)
|
2000-09-08 |
2000-10-25 |
Inst Of Molecul & Cell Biology |
Novel protein tyrosine phosphatase inhibitor
|
|
JP2002114768A
(ja)
|
2000-10-11 |
2002-04-16 |
Japan Tobacco Inc |
２−（２，５−ジハロゲン−３，４−ジヒドロキシフェニル）アゾール化合物及びそれを含有してなる医薬組成物
|
|
US20030108883A1
(en)
|
2001-02-13 |
2003-06-12 |
Rondinone Cristina M. |
Methods for identifying compounds that inhibit or reduce PTP1B expression
|
|
US20030120073A1
(en)
|
2001-04-25 |
2003-06-26 |
Seto Christopher T. |
Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases
|
|
JP2002322054A
(ja)
|
2001-04-26 |
2002-11-08 |
Dai Ichi Seiyaku Co Ltd |
薬剤排出ポンプ阻害薬
|
|
WO2002102813A1
(en)
|
2001-06-20 |
2002-12-27 |
Merck Frosst Canada & Co. |
Aryldifluoromethylphosphonic acids for treatment of diabetes
|
|
US20030064979A1
(en)
|
2001-06-29 |
2003-04-03 |
Hansen Thomas Kruse |
Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
|
|
US20030170660A1
(en)
|
2001-07-11 |
2003-09-11 |
Sondergaard Helle Bach |
P387L variant in protein tyrosine phosphatase-1B is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro
|
|
CA2463441A1
(en)
|
2001-10-12 |
2003-05-08 |
Bayer Pharmaceuticals Corporation |
Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
|
|
EP1438044A1
(en)
|
2001-10-19 |
2004-07-21 |
Transtech Pharma, Inc. |
Bis-heteroaryl alkanes as therapeutic agents
|
|
ATE348828T1
(de)
|
2001-10-19 |
2007-01-15 |
Transtech Pharma Inc |
Beta-carbolin-derivate als ptp-inhibitoren
|
|
WO2003048140A1
(en)
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
|
JP2003231679A
(ja)
|
2001-12-03 |
2003-08-19 |
Japan Tobacco Inc |
アゾール化合物及びその医薬用途
|
|
US6642381B2
(en)
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
|
US20030180827A1
(en)
|
2002-01-04 |
2003-09-25 |
Aventis Pharma Deutschland Gmbh. |
Highly sensitive and continuous protein tyrosine phosphatase test using 6,8-difluoro-4-methylumbelliferyl phosphate
|
|
US20030215899A1
(en)
|
2002-02-13 |
2003-11-20 |
Ceptyr, Inc. |
Reversible oxidation of protein tyrosine phosphatases
|
|
US6784205B2
(en)
|
2002-03-01 |
2004-08-31 |
Sunesis Pharmaceuticals, Inc. |
Compounds that modulate the activity of PTP-1B and TC-PTP
|
|
JP4481011B2
(ja)
|
2002-03-05 |
2010-06-16 |
トランス テック ファーマ，インコーポレイテッド |
リガンドのｒａｇｅとの相互作用を阻害する単環式および二環式アゾール誘導体
|
|
IL164262A0
(en)
|
2002-04-03 |
2005-12-18 |
Novartis Ag |
5-Substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors
|
|
WO2003086390A1
(en)
|
2002-04-12 |
2003-10-23 |
Pfizer Japan Inc. |
Imidazole compounds as anti-inflammatory and analgesic agents
|
|
JP4529342B2
(ja)
|
2002-04-23 |
2010-08-25 |
東ソー株式会社 |
環状アミジニウム有機酸塩の製造方法
|
|
JP2003313172A
(ja)
|
2002-04-23 |
2003-11-06 |
Tosoh Corp |
Ｎ−置換イミダゾール化合物の製造方法
|
|
AU2003228744A1
(en)
|
2002-04-29 |
2003-11-17 |
The Ohio State University |
Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic
|
|
US7399586B2
(en)
|
2002-05-23 |
2008-07-15 |
Ceptyr, Inc. |
Modulation of biological signal transduction by RNA interference
|
|
US6849761B2
(en)
|
2002-09-05 |
2005-02-01 |
Wyeth |
Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia
|
|
EP1402888A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
The use of substituted carbocyclic compounds as rotamases inhibitors
|
|
AU2003300447B2
(en)
|
2002-12-30 |
2009-09-03 |
Vertex Pharmaceuticals Incorporated |
Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
WO2004071448A2
(en)
|
2003-02-12 |
2004-08-26 |
Transtech Pharma Inc. |
Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
|
|
JP2006518738A
(ja)
|
2003-02-12 |
2006-08-17 |
トランス テック ファーマ，インコーポレイテッド |
治療薬としての置換アゾール誘導体
|
|
US20040167188A1
(en)
|
2003-02-14 |
2004-08-26 |
Zhili Xin |
Protein-tyrosine phosphatase inhibitors and uses thereof
|
|
MXPA05010945A
(es)
|
2003-04-09 |
2005-11-25 |
Japan Tobacco Inc |
Compuesto pentaciclico heteroaromatico y uso medicinal del mismo.
|
|
US7141596B2
(en)
|
2003-10-08 |
2006-11-28 |
Incyte Corporation |
Inhibitors of proteins that bind phosphorylated molecules
|
|
JP4898458B2
(ja)
*
|
2004-02-12 |
2012-03-14 |
トランス テック ファーマ，インコーポレイテッド |
置換アゾール誘導体、組成物及び使用方法
|
|
CN101312957A
(zh)
*
|
2005-12-08 |
2008-11-26 |
诺瓦提斯公司 |
用于治疗由蛋白酪氨酸磷酸酶介导的疾病(ptpase)的1,2,5-噻唑烷衍生物
|
|
CA2630448A1
(en)
*
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
1,1,3-trioxo-1,2,5-thiadiazolidines and their use as ptp-ases inhibitors
|
|
BRPI0707338A2
(pt)
*
|
2006-01-30 |
2011-05-03 |
Transtech Pharma Inc |
derivados de imidazol, composições, e métodos substituìdos de uso como inibidores de ptpase
|